Medytox, Stock Price Down 0.58% at This Hour... 'Worst Expected Performance Due to Provisional Sales Suspension and COVID-19 Virus'

Medytox is trading at 139,700 KRW as of 9:30 AM on the 19th, up 0.58% from the previous day. The trading volume is 57,286 shares, which is about 19.88% of the previous day's volume. Medytox is known as a manufacturer and seller of pharmaceuticals and cosmetic pharmaceuticals.

On May 18, Hana Financial Investment analyst Minjeong Seon stated, "The decline in toxin exports due to the COVID-19 pandemic has led to a deterioration in Medytox's performance, and the resulting stock price drop is inevitable. However, the recent sharp decline caused by many uncertainties could rebound once those uncertainties are resolved. The preliminary ITC ruling is scheduled to be announced on June 5, Eastern Time. After the announcement, a significant portion of the uncertainties surrounding Medytox is expected to be resolved." She set the target price for Medytox at 260,000 KRW.

Over the past five days, individual investors have net purchased 51,870 shares of Medytox, while foreign investors and institutions have net sold 72,491 shares and net purchased 23,001 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.